Immunology and inflammation: Type I allergy and intolerance

Journal of Dermatological Treatment

Volumn 11, Issue SUPPL. 1, 2000, Pages 27-30

  Greaves, M W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; High affinity IgE receptors; IgE; Immunotherapy; Mast cells; Urticaria

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN; HISTAMINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIGAND; LIPOXYGENASE INHIBITOR; PEPTIDE;

CELL ACTIVATION; CHRONIC DISEASE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; LABORATORY TEST; MAST CELL; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIDE EFFECT; URTICARIA;

EID: 0033932626     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466300750163681     Document Type: Review

References (15)

1. Sabroe RA, Francis DM, Barr RM et al, Anti-FcεRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol (1998) 102: 651-8.
2. Kaplan AP, Horokova Z, Katz SI, Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol (1978) 61: 350-4.
3. Barlow RJ, Ross EL, MacDonald D et al, Mast cells and T-lymphocytes in chronic urticaria. Clin Exp Allergy (1995) 25: 317-22.
4. Niimi N, Francis DM, Kermani F et al, Dermal mast cell activation by autoantibodies against the high-affinity IgE receptor in chronic urticaria. J Invest Dermatol (1996) 106: 1001-6.
5. Hide M, Francis DM, Grattan CEH et al, Autoantibodies against the high-affinity IgE receptor as a cause for histamine released in chronic urticaria. N Engl J Med (1993) 328: 1599-604.
6. Fiebiger E, Maurer D, Holub H et al, Serum IgG autoantibodies directed against the alpha-chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria. J Clin Invest (1995) 96: 606-12.
7. Tong LJ, Balakreshnan G, Kochan JP et al, Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol (1997) 99: 461-5.
8. Zweiman B, Valenzano M, Atkins PC et al, Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol (1996) 98: 89-98.
9. Fiebiger E, Hammerschmid F, Stingl G, Maurer D, Anti-FcεRI autoantibodies in autoimmune-mediated disorder: identification of a structure-function relationship. J Clin Invest (1998) 101: 245-51.
10. Sabroe RA, Grattan CEH, Francis DM et al, The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol (1999) 140: 446-52.
11. Grattan CEH, Francis DM, Slater NGP et al, Plasmapheresis for severe unremitting chronic urticaria, Lancet (1992) 39: 1078-80.
12. O'Donnell BF, Barr RM, Black AK et al, Intravenous immunoglobulin in chronic autoimmune urticaria. Br J Dermatol (1998) 138: 101-6.
13. Grattan CEH, O'Donnell BF, Francis DM et al, Randomised double-blind study of cyclosporin in chronic idiopathic urticaria. Br J Dermatol (2000: in press).
14. Sabroe RA, Poon E, Orchard GE et al, Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Allergy Clin Immunol (1999) 103: 484-91.
15. Ellis MH, Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol (1998) 102: 876-7.